VeriPair™ T-bet Lentiviral Dual-Reporter System

Overview

The VeriPair™ platform is LipExoGen’s integrated dual-reporter system for pathway analysis, combining a pathway-responsive experimental reporter with a constitutive internal control in the same construct. This design reduces variability from transduction efficiency, genomic integration, and cell number while supporting cleaner, more scalable assay workflows.

T-bet is measured using pathway-responsive T-bet elements driving the experimental reporter, alongside an EF1α-driven internal control cassette for normalization. This parent product groups the three VeriPair modalities: RedShift, Luciferase, and Fluorescence.

Product Data:

Advantages

• Single-construct dual-reporter design with built-in normalization.
• Premium RedShift tier enables one-step same-well luminescence on compatible instruments.
• Luciferase and fluorescence tiers provide flexible detection options across different labs and instruments.
• Direct pathway-specific analog to the corresponding TF Reporter Lentivirus source product.

Applications

• Pathway activity quantification with stronger normalization.
• Industry-friendly assay simplification and automation workflows.
• Stable line generation using the same integrated dual-reporter logic.